Biotechnology & Pharmaceutical
Life-improving innovations in biotechnology and pharmaceuticals require intellectual property counsel with unique technical and legal expertise to protect the assets upon which companies are established and flourish. The BioPharma Group at Brinks Gilson & Lione includes attorneys and patent agents who counsel a diverse array of clients — from start-ups to prestigious academic institutions to global corporations — on the ever-evolving laws concerning intellectual property in the United States and worldwide.
The BioPharma Group has key experience and success with biopharma litigation, including Hatch-Waxman cases, USPTO proceedings, biopharma patent drafting and prosecution, and licensing and evaluation of biopharma intellectual property. Our BioPharma Group members hold wide-ranging science and engineering degrees, many at the advanced level, and have extensive industry work experience or education in scientific disciplines, including chemistry, pharmacology, immunoassay test development, small molecule organic chemistry, cell biology and genetics.